Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2009
12/02/2009CN101595107A Substituted piperidines that increase P53 activity and the uses thereof
12/02/2009CN101595106A Substituted gamma lactams as therapeutic agents
12/02/2009CN101595105A 2-substituted 5-membered heterocycles as SCD inhibitors
12/02/2009CN101591334A Photochromic thiophene-thiazole heterocycle hybrid asymmetric perfluorocyclopentene compound, preparation method and application
12/02/2009CN101591332A Compound based on 4-phenyl-6-(2, 2, 2-trifluoro-1-phenylethoxy) pyridine and application method thereof
12/02/2009CN101591295A Water-soluble benzopyrazolyl quaternary ammonium salt, preparation method thereof and application thereof
12/02/2009CN101591281A Phosphonate compounds having immuno-modulatory activity
12/02/2009CN100564377C Substituted 4H-chromenes and analogs as activators of caspase and inducers of apoptosis and use thereof
12/02/2009CN100564358C Method for making 4-(3,4-dichlorophenoxy)piperidine
12/02/2009CN100564344C 2- and 2,5-substituted phenylketo-enols
12/02/2009CN100563650C Indol-6 sulfonamide derivatives, their preparation and their use as 5-ht-6 modulators
12/01/2009US7626038 Method for manufacturing enantiomeric imidazole compounds
12/01/2009US7625944 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment
12/01/2009US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
12/01/2009US7625934 Metalloproteinase inhibitors
12/01/2009US7625932 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
12/01/2009US7625926 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
12/01/2009US7625914 2(S)-Ethoxy-3-{4-[2-(3-heptyl-1-methylureido)thiazol-4-yl]phenyl}propanoic acid; dermatology, and cardiovascular diseases, immune diseases, lipid metabolism diseases; veterinary medicine
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009US7625908 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
12/01/2009US7625901 for treating migraine, headaches; 2-[(8S)-8-(3,5-Difluorophenyl)-6-oxo-7-azaspiro[4.5]dec-7-yl]-N-(2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2-yl)acetamide
12/01/2009US7625841 invention also relates to the preparation of the compounds, to their use as herbicides and to herbicidal compositions comprising the novel compounds.
12/01/2009CA2461100C 4-imidazolin-2-one compounds
12/01/2009CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
11/2009
11/26/2009WO2009143153A1 Substituted pyrrolidine amides as modulators of the histamine h3 receptor
11/26/2009WO2009142984A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/26/2009WO2009142969A1 Therapeutic lactams
11/26/2009WO2009142571A1 Phenyl and benzodioxinyl substituted indazoles derivatives
11/26/2009WO2009142569A1 Phenyl or pyridinyl substituted indazoles derivatives
11/26/2009WO2009142321A1 Novel thiophenediamine derivative having urea structure
11/26/2009WO2009141292A1 Substituted heteroarylmethyl sulfonamides
11/26/2009WO2009141274A1 Substituted pyridin-4 -yl-methyl sulfonamides as fungicides
11/26/2009WO2009123948A3 Compounds and compositions as itpkb inhibitors
11/26/2009US20090292121 Cyanopyridine derivative and use thereof as medicine
11/26/2009US20090291979 Tricyclic-bridged piperidinylidene derivatives as delta opioid modulators
11/26/2009US20090291969 Fungicide hydroximoyl-tetrazole derivatives
11/26/2009CA2725140A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/26/2009CA2724584A1 Phenyl or pyridinyl substituted indazoles derivatives
11/26/2009CA2724508A1 Phenyl and benzodioxinyl substituted indazoles derivatives
11/26/2009CA2724467A1 Therapeutic lactams
11/26/2009CA2724357A1 Novel thiophenediamine derivative having urea structure
11/25/2009EP2121672A2 Substituted gamma lactams as therapeutic agents
11/25/2009EP2121659A1 Modulators of cb1 receptors
11/25/2009EP2121648A2 S1p receptor modulating compounds and use thereof
11/25/2009EP2121630A1 Fast dissociating dopamine 2 receptor antagonists
11/25/2009EP2121619A2 Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
11/25/2009EP2121617A1 Cb1 receptor modulators
11/25/2009EP2121608A1 Dihydropyridine derivatives useful as protein kinase inhibitors
11/25/2009EP2121584A2 Novel herbicides
11/25/2009EP2121583A1 Heteroaryl-substituted serine amides
11/25/2009EP1848694B1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
11/25/2009EP1144405B1 Triazole compounds with dopamine-d3-receptor affinity
11/25/2009EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides
11/25/2009CN101589024A Novel minor groove binders
11/25/2009CN101585802A Organic luminescent material 9-(4-aryl ethynyl phenyl) carbazoles compounds, synthesis method and uses
11/25/2009CN101584691A Compounds effecting glucokinase
11/25/2009CN100562518C Novel arylethene-sulfonamides compounds
11/24/2009US7622487 Piperidine derivative, process for producing the same, and use
11/24/2009US7622474 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis
11/24/2009CA2526145C C-glycoside derivatives or salts thereof for use as na+-glucose cotransporter inhibitors
11/24/2009CA2485926C (imidazol-1-yl-methyl)-pyridazine as nmda receptor blocker
11/24/2009CA2433197C Gyrase inhibitors and uses thereof
11/19/2009WO2009140475A1 Hepatitis c virus inhibitors
11/19/2009WO2009139870A1 Oxo-imidazolyl compounds having antibacterial activity
11/19/2009WO2009139373A1 Amide compound
11/19/2009WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009WO2009138763A1 Formation of 18f and 19f fluoroarenes bearing reactive functionalities
11/19/2009WO2009138416A1 Oxime carbamoyl derivatives as modulators of fatty acid amides hydrolase
11/19/2009WO2009094442A3 5-fluoro pyrimidine derivatives as fungicides
11/19/2009US20090286992 Formation of 18f and 19f fluoroarenes bearing reactive functionalities
11/19/2009US20090286986 Isoindole-imide compounds, compositions, and uses thereof
11/19/2009US20090286840 Polo-like kinase inhibitors such as 5-(5-Amino-2H-pyrazol-3-yl)-3-[1-(2-chloro-phenyl)-ethoxy]-thiophene-2-carboxylic acid amide, useful for treating or preventing autoimmune, inflammatory, proliferative or hyperproliferative disease, a neurodegenerative disease, or an immunologically-mediated disease
11/19/2009US20090286786 Compounds having a 4-pyridylalkylthio group as a substituent
11/19/2009US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009CA2724077A1 Amide compound
11/19/2009CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/18/2009EP2119703A1 Novel indole derivative having inhibitory activity on i b kinase
11/18/2009EP2118094A1 Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure
11/18/2009EP2118093A1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
11/18/2009EP2118067A1 Nicotinic acetylcholine receptor modulators
11/18/2009EP2117523A1 Inhibitors of akt activity
11/18/2009EP1888538B1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/18/2009EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/18/2009EP1280781B1 5-ht 7 receptor antagonists
11/18/2009EP1218354B1 Quinazoline derivatives and their use as pharmaceuticals
11/18/2009EP1184379B1 Chromene compound
11/18/2009EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators
11/18/2009CN101583611A Inhibitors of hepatitis C virus
11/18/2009CN101580503A Green synthesis method of furane derivative
11/18/2009CN101580498A Green synthesis method of furane derivative
11/18/2009CN101580489A Nitrogenous heterocyclic ring compound and preparation method and application thereof
11/18/2009CN100560073C N4-acylcytosine nucleosides for treatment of viral infections
11/17/2009US7619096 3-Aminopyrrolidines as inhibitors of monoamine uptake
11/17/2009US7619092 Such as (2R,4S)-1-{N-(3,5-bistrifluoromethylbenzyl)-N-methyl}-aminocarbonyl-2-(4-fluoro-2-methylphenyl)-4-(2-hydroxyethoxy)-piperidine; tachykinin receptor antagonists
11/17/2009US7619091 Treating nervous system disorders such as mild cognitive impairment, Alzheimer's disease or dementia associated with Down syndrome; e.g. use of 5,7-dichloro-8-hydroxy-2-(2-pyridyl)-quinoline (PBT 1052)
11/17/2009CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009CA2422925C .delta.1-pyrrolines used as pesticides
11/17/2009CA2398992C Therapeutic or preventive agent for pulmonary insufficiency containing a diaminotrifluoromethylpyridine derivative
11/17/2009CA2272460C Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
1 ... 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 ... 523